Capitalizator.

Capitalize Yourself: Right Data. Real Growth.

Company Analysis

CELL Insider Trading

CELL | Market Equity

Comprehensive Trading Performance Summary

The investment history of corporate insiders at CELL provides a unique lens into the internal conviction of the company's leadership. By analyzing SEC Form 4 filings, investors can track how directors and officers are allocating their own capital. High-conviction buying often signals that management believes the current market price significantly undervalues future growth prospects, while strategic selling might occur for personal liquidity or portfolio diversification. Monitoring these shifts in ownership is essential for understanding the alignment between management and shareholders in the Market Equity sector.

Transactions on Chart

Open Full Chart
Filing Date Trade Date Reporting Person Relationship Type Price Qty Total, $ Owned After Change, %
2012-09-07 13:38 2012-09-05 RINGROSE PAUL A Other SELL $8.98 11,880 $106,682 0 -100.0%
2012-08-28 20:50 2012-08-27 THOMLINSON R BRUCE Other SELL $8.95 61,243 $548,125 165,368 -27.0%
2012-08-20 22:37 2012-08-15 MACKLE ANTHONY Other SELL $8.96 12,608 $112,968 12,636 -49.9%
2012-05-31 17:57 2012-05-29 Ward Thomas Officer - VP Inv Relations and PR BUY $5.00 1,250 $6,250 2,619 +91.3%
2012-05-02 23:13 2012-05-01 ROEDEL RICHARD Director BUY $6.11 24,500 $149,742 124,238 +24.6%
2012-03-16 17:48 2012-03-14 CARPENTER CRAIG Officer - EVP, General Counsel SELL $8.43 4,649 $39,191 14,499 -24.3%
2012-03-09 00:31 2012-03-07 RINGROSE PAUL A Other SELL $8.19 10,579 $86,617 0 -100.0%
2012-03-07 20:50 2012-03-06 THOMLINSON R BRUCE Other SELL $8.35 50,000 $417,500 226,611 -18.1%
2012-02-28 01:09 2012-02-23 Lucchese Cynthia L Director BUY $8.97 3,000 $26,910 8,000 +60.0%
2012-02-24 23:35 2012-02-23 RINGROSE PAUL A Other SELL $9.02 10,510 $94,851 0 -100.0%
2012-02-23 00:00 2012-02-17 Anderson Chad Officer - CFO, Brightpoint EMEA OPT+S $10.06 7,618 $76,636 9,075 0.0%
2012-02-15 00:22 2012-02-10 Currie John Alexander Du Plessis Other OPT+S $10.00 127,888 $1,278,880 65,686 0.0%
2012-02-13 23:01 2012-02-10 SMITH MICHAEL L Director BUY $10.00 25,000 $250,000 25,000 +100.0%
2012-02-11 00:56 2012-02-10 LEVY JOHN F Director BUY $9.97 1,000 $9,970 6,000 +20.0%
2011-11-16 23:29 2011-11-16 LEVY JOHN F Director BUY $10.14 1,000 $10,140 5,000 +25.0%
2011-11-02 20:56 2011-11-02 LUDWIG JOHN J Other SELL $10.03 6,345 $63,656 2,000 -76.0%
2011-08-23 18:52 2011-08-22 Ridge Thomas J Director BUY $8.08 10,000 $80,846 15,000 +200.0%
2011-08-11 18:58 2011-08-09 Ridge Thomas J Director BUY $7.83 5,000 $39,150 5,000 +100.0%
2011-08-11 19:10 2011-08-11 LEVY JOHN F Director BUY $7.93 1,000 $7,930 4,000 +33.3%
2011-05-20 17:36 2011-05-19 LEVY JOHN F Director BUY $8.85 1,000 $8,848 3,000 +50.0%
2011-05-17 21:03 2011-05-13 Lucchese Cynthia L Director BUY $8.91 5,000 $44,550 5,000 +100.0%
2011-03-16 23:27 2011-03-15 DONARGO VINCENT Officer - Chief Accounting Officer SELL $12.23 14,769 $180,629 19,053 -43.7%
2011-03-11 23:24 2011-03-10 Paskoff Alex Officer - Exec VP, Americas - Bus Dev. SELL $12.30 4,767 $58,614 0 -100.0%
2011-03-10 22:24 2011-03-10 LEVY JOHN F Director BUY $12.28 1,000 $12,279 2,000 +100.0%
2011-02-28 19:06 2011-02-25 Hanley Robert Officer - VP, Human Resources SELL $12.50 1,433 $17,913 0 -100.0%
2011-02-28 23:09 2011-02-24 FIVEL STEVEN E Officer - EVP & General Counsel SELL $12.19 48,185 $587,182 0 -100.0%
2011-02-28 19:10 2011-02-25 THOMLINSON R BRUCE Other SELL $12.40 57,129 $708,400 165,368 -25.7%
2011-02-28 18:32 2011-02-25 BOOR ANTHONY W Officer - EVP, Chief Financial Officer SELL $12.24 26,445 $323,687 29,467 -47.3%
2011-02-23 17:17 2011-02-18 Anderson Chad Officer - CFO, Brightpoint EMEA OPT+S $12.79 2,373 $30,351 3,201 0.0%
2011-02-17 19:27 2011-02-16 Currie John Alexander Du Plessis Other SELL $12.88 6,884 $88,666 107,898 -6.0%
2011-02-16 23:12 2011-02-14 HOWELL J MARK Officer - President Americas, Co-COO OPT+S $12.75 6,864 $87,516 320,719 0.0%
2011-02-14 22:58 2011-02-10 Currie John Alexander Du Plessis Other SELL $12.80 84,006 $1,075,277 105,000 -44.4%
2011-02-11 23:25 2011-02-10 FIVEL STEVEN E Officer - EVP & General Counsel SELL $12.79 19,471 $249,079 47,655 -29.0%
2011-02-11 23:19 2011-02-09 THOMLINSON R BRUCE Other SELL $12.50 40,521 $506,513 165,368 -19.7%
2011-02-11 23:22 2011-02-09 BOOR ANTHONY W Officer - EVP, Chief Financial Officer SELL $12.35 25,632 $316,558 16,081 -61.4%
2011-02-10 23:12 2011-02-08 Polk Ryan Officer - Strategy Planning and IR SELL $12.70 3,500 $44,450 499 -87.5%
2011-02-08 21:52 2011-02-07 Polk Ryan Officer - Strategy Planning and IR SELL $12.70 100 $1,270 3,999 -2.4%
2011-02-08 01:09 2011-02-04 LAIKIN ROBERT J Director, Officer - Chief Executive Officer OPT+S $12.35 87,505 $1,080,897 0 0.0%
2011-02-08 00:46 2011-02-04 Anderson Chad Officer - CFO, Brightpoint EMEA OPT+S $12.28 8,240 $101,201 3,201 0.0%
2011-02-08 01:13 2011-02-04 Paskoff Alex Officer - Exec VP, Americas - Bus Dev. OPT+S $12.26 2,273 $27,867 0 0.0%
2011-02-08 00:51 2011-02-04 CARPENTER CRAIG Officer - VP, Deputy General Counsel OPT+S $12.22 13,000 $158,839 1,373 0.0%
2011-02-08 00:56 2011-02-04 CYR ANNETTE W Other OPT+S $12.10 12,563 $152,012 17,785 0.0%
2011-02-08 01:02 2011-02-04 FIVEL STEVEN E Officer - EVP & General Counsel OPT+S $12.16 43,550 $529,703 67,126 0.0%
2011-02-08 01:11 2011-02-04 LUDWIG JOHN J Other OPT+S $12.17 10,951 $133,276 4,851 0.0%
2011-02-08 01:06 2011-02-04 HOWELL J MARK Officer - President Americas, Co-COO OPT+S $12.19 28,907 $352,376 320,719 0.0%
2011-02-08 01:04 2011-02-04 GUPTA ANURAG Other OPT+S $12.24 34,903 $427,300 1,376 0.0%
2010-12-14 00:19 2010-12-09 LAIKIN ROBERT J Director, Officer - Chief Executive Officer SELL $8.82 41,995 $370,404 2,500 -94.4%
2010-12-03 16:56 2010-12-01 Currie John Alexander Du Plessis Other SELL $8.55 13,482 $115,271 172,340 -7.3%
2010-11-24 21:59 2010-11-24 LEVY JOHN F Director BUY $8.75 1,000 $8,750 1,000 +100.0%
2010-11-10 21:27 2010-11-08 Paskoff Alex Officer - Exec VP, Americas - Bus Dev. SELL $9.02 9,196 $82,976 0 -100.0%
SHOW ENTRIES

How to Interpret $CELL Trades

Not every insider transaction in CELL is a signal for immediate action. Professional investors look for "cluster buying"—when multiple executives simultaneously purchase $CELL shares on the open market. It is crucial to distinguish between scheduled sales (under Rule 10b5-1) and voluntary increases in ownership, which demonstrate management’s true conviction that the stock is undervalued.

Data Source & Accuracy for CELL

Insider activity data for CELL is streamed in real-time directly from the SEC EDGAR system. We analyze raw Form 4 filings, filtering out technical adjustments and complex derivative transactions. This provides a transparent view of how ownership structure is evolving in $CELL, allowing you to follow the capital of those with the most intimate knowledge of the company.

UNDERSTANDING THE DATA

FILING DATE: The date and time when the transaction was reported to the SEC. This is when the public first receives the information.

TRADE DATE: The actual day the insider executed the purchase or sale in the market.

INDUSTRY: The specific market sector the company operates in. Useful for identifying broader institutional capital flows across sectors.

OWNED AFTER: The total number of shares held by the insider following the transaction. This highlights the insider's remaining conviction in the company.

CHANGE %: The percentage increase or decrease of the insider's total position. Large percentage changes often carry more weight than the dollar amount alone.

TRADE TYPES DEFINITIONS

BUY: An open market purchase. Typically indicates an insider's belief that the stock is undervalued or poised for growth.

SELL: An open market sale. While often used for diversification or liquidity, large or unexpected sales can be a warning signal.

OPT+S (OPTION EXERCISE & SALE): This occurs when an insider exercises their stock options and sells them immediately. Often part of a structured compensation plan.